Evidence map›Paper›PMID 38335156›Full record

ArticlePloS one2024

High dose rate 192Ir brachytherapy source model Monte Carlo dosimetry: mHDR-v2 and mHDR-v2r.

Shuhei Tsuji, Naomasa Narihiro, Masataka Oita, Yoshihito Namito, Hideo Hirayama

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shuhei TsujiNatural Sciences, Kawasaki Medical School, Kurashiki, Japan.ORCID 0000-0002-6856-0296
Naomasa NarihiroDepartment of Radiological Technology Faculty of Health Science and Technology, Kawasaki University of Medical Welfare, Kurashiki, Japan.
Masataka OitaDepartment of Graduate School of Interdisciplinary Sciences and Engineering in Health Systems, Okayama University, Kita-ku Okayama, Japan.ORCID 0000-0002-8667-6209
Yoshihito NamitoHigh Energy Accelerator Research Organization, KEK, Tsukuba, Japan.
Hideo HirayamaHigh Energy Accelerator Research Organization, KEK, Tsukuba, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After 2010, the source model of the microSelectron HDR Afterloader System was slightly modified from the previous model. Granero et al. named the modified source model "mHDR-v2r (revised model mHDR-v2)" and the previous model "mHDR-v2". They concluded that the dosimetric differences arising from the dimensional changes between the mHDR-v2 and mHDR-v2r designs were negligible at almost all locations (within 0.5% for r ≥ 0.25 cm), the two-dimensional anisotropy function difference between the two sources is found 2.1% at r = 1.0 cm when compared with the results of the other experimental group. To confirm this difference, we performed a full Monte Carlo simulation without energy-fluence approximation. This is useful near the radiation source where charged-particle equilibrium does not hold. The two-dimensional anisotropy function of the TG-43U1 dataset showed a few percent difference between the mHDR-v2r and mHDR-v2 sources. There was no agreement in the immediate vicinity of the source (0.10 cm and 0.25 cm), when compared to Granero et al. in mHDR-v2r sources. The differences in these two-dimensional anisotropy functions were identified.

Indexed as

BrachytherapyIridium RadioisotopesMonte Carlo MethodRadiometryRadiotherapy DosageIridium-192Iridium Radioisotopes

Identifiers

PMID38335156
PMCPMC10857611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.